J Korean Ophthalmol Soc.  2024 Sep;65(9):589-595. 10.3341/jkos.2024.65.9.589.

The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery

• Suh JH
• Chung SK

• KMID: 2559015
• DOI: http://doi.org/10.3341/jkos.2024.65.9.589

Abstract

Purpose
To evaluate the potential advantages of using topical rebamipide 2% to manage dry eye following cataract surgery.
Methods
Patients who underwent cataract surgery (phacoemulsification and intraocular lens insertion) were evaluated for dry eye 1 week postoperatively. Randomly selected patients were divided into the rebamipide group, who received 2% rebamipide eye drops, and the control group, who did not receive rebamipide. Various dry eye-related tests, including Schirmer’s test, the tear break-up time (TBUT), ocular surface staining, tear film osmolarity, tear lipid layer thickness, and the ocular surface disease index (OSDI) were performed in both groups 1 week, and 1 and 2 months postoperatively.
Results
In the rebamipide group, we observed significant improvement in TBUT, the ocular surface staining score, and OSDI at 2 months postoperatively, as compared to 1 week (p = 0.002, 0.014, and 0.013, respectively). Schirmer’s test, tear film osmolarity, and tear lipid layer thickness remained unchanged in the rebamipide group. Throughout the entire follow-up period, the rebamipide group had a significantly prolonged TBUT (1 month: p = 0.007, 2 months: p = 0.000), and lower ocular surface staining score (1 month: p = 0.000, 2 months: p = 0.000), as compared to the control.
Conclusions
Following cataract surgery, the use of rebamipide eye drops produced improvements in TBUT, ocular surface staining scores, and OSDI. This suggests that rebamipide offers benefits in managing dry eye that can occur after cataract surgery.

Keyword

Cataract extraction, Dry eye syndromes, Mucin, Quinolones, Rebamipide